Deanna Nguyen
Optometrist · San Francisco, CANPI 1447626338
Payments from drug & device makers
Across 95 payments — averaging $24.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$289
- Tarsus Pharmaceuticals, Inc.$258
- Alcon$249
- Bausch & Lomb Americas Inc.$192
- Sight Sciences, Inc.$149
- Dompe US, Inc.$128
- plus $1K from 15 others
What the payments were for
- Food & beverage$2,28198%
- Gifts$191%
- Entertainment$251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 12 | $289 |
| Tarsus Pharmaceuticals, Inc. | 11 | $258 |
| Alcon | 11 | $249 |
| Bausch & Lomb Americas Inc. | 9 | $192 |
| Sight Sciences, Inc. | 5 | $149 |
| Dompe US, Inc. | 5 | $128 |
| Johnson & Johnson Vision Care, Inc. | 5 | $124 |
| Johnson & Johnson Surgical Vision, Inc. | 5 | $119 |
| Thea Pharma Inc. | 5 | $113 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $112 |
| Oyster Point Pharma, Inc. | 4 | $108 |
| Rxsight Inc | 4 | $93 |
| Sun Pharmaceutical Industries Inc. | 3 | $71 |
| Harrow Eye, LLC | 2 | $66 |
| Carl Zeiss Meditec USA, Inc. | 1 | $60 |
| Kala Pharmaceuticals, Inc. | 2 | $47 |
| Novartis | 2 | $39 |
| Biotissue Holdings Inc. | 1 | $37 |
| Aerie Pharmaceuticals, Inc. | 1 | $26 |
| Optos, Inc. | 1 | $25 |
| Carl Zeiss Meditec AG | 1 | $19 |
How this compares
$2,326 in reported general payments places this provider in the 80th percentile of 6,778 optometrist providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 16 | $16,275 |
| Timolol Maleate | 39 | $1,982 |
| Prednisolone Acetate | 17 | $686 |
| Latanoprost | 81 | $663 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 15 | $182 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis | $289 | $16,27516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,778 optometrist providers in California.
Other optometrist in San Francisco
- Selena ChanSan Francisco$677K
- Kim LeeSan Francisco$162K
- Randall GoSan Francisco$146K
- Meng LinBerkeley$6.9M
- Steve YoelinNewport Beach$6.1M
- Matthew GellerSpring Valley$3.5M
- David Kasanoffla Mesa$1M
- Colton HeinrichFullerton$987K
- Elsa PaoOakland$910K
- Keith WanSan Diego$887K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.